Chemours Posts $196 Million Quarterly Profit, But Adjusted Net Income Is Just $31 Million

A $150 million PFAS insurance receipt flattered the third quarter, and the company guides to a weaker fourth quarter.

Share
Chemours Posts $196 Million Quarterly Profit, But Adjusted Net Income Is Just $31 Million

Chemours, which makes refrigerants, titanium dioxide pigment and fluoropolymer resins, reported third-quarter net income of $196 million, or $1.29 per diluted share, in results released Monday. Adjusted net income was only $31 million, or $0.21 per share, and the company guided to a softer fourth quarter.

A profit inside a year-to-date loss

Net income compares with $46 million, or $0.31 per share, a year earlier and a loss of $274 million in the second quarter. For the first nine months, Chemours still shows a net loss attributable to the company of $107 million.

The quarter included $150 million received under a PFAS insurance proceeds agreement tied to the finalized New Jersey consent order, booked as a reduction to selling, general and administrative expense. Adjusted net income, which strips out litigation settlements, environmental charges and asset-sale gains among other items, was $26 million a year earlier and $64 million in the second quarter.

Adjusted EBITDA, a measure of core operating earnings, was $200 million, against $189 million a year earlier and $247 million in the second quarter.

Pigment prices up, refrigerants down

Net sales were $1.54 billion, up about 3% from a year earlier, on roughly 5% higher prices partly offset by 2% lower volumes. Chemours is a chemicals maker serving markets from air conditioning to coatings, semiconductors and oil and gas.

  • Titanium Technologies sales rose 11% to $680 million, with a 10% price increase, and adjusted EBITDA climbed to $85 million from $25 million.
  • Advanced Performance Materials sales rose 8% to $337 million, led by a 26% jump in Performance Solutions products for data center and semiconductor customers.
  • Thermal & Specialized Solutions sales fell 9% to $510 million, and adjusted EBITDA dropped 30% to $136 million.

Opteon refrigerant sales fell 22% to $287 million. The company blamed lower North American stationary air-conditioning aftermarket sales compared with elevated demand a year earlier, when channels were first filled during the technology transition under the U.S. AIM Act.

CEO Denise Dignam said the company continues to "navigate TSS stationary aftermarket dynamics and a softer macroeconomic environment."

Fourth-quarter guidance and leverage

For the fourth quarter, Chemours expects net sales to fall 5% to 10% from the third quarter, citing seasonality, with adjusted EBITDA of $160 million to $185 million. For 2026 it expects sales growth of about 2% and adjusted EBITDA of $775 million to $800 million.

Debt net of cash was $3.2 billion at September 30, a net leverage ratio of about 4.3x adjusted EBITDA over the trailing twelve months. The company now expects to get below 4.2x in 2026. Total liquidity was $1.7 billion.

Third-quarter operating cash flow was $149 million, and free cash flow was $98 million, versus $105 million a year earlier.

Chemours holds its earnings call and webcast at 8:00 a.m. Eastern on Tuesday.

Sources